TYRA
Tyra Biosciences, Inc.
Key Financials
Operating Income
$-132762000
↓ 27.4%
Total Assets
$282.6M
↓ 22.3%
Total Liabilities
$23.4M
↑ 14.8%
Net Income
$-119947000
↓ 38.7%
EPS (Diluted)
$-2.01
↓ 33.1%
Cash & Equivalents
$77.4M
↓ 15.9%
Operating Cash Flow
$-95142000.00
↓ 36.4%
Shareholders' Equity
$259.2M
↓ 24.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TYRA |
| Company Name | Tyra Biosciences, Inc. |
| CIK | 1863127 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (619) 728-4760 |